Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review

Choi Franchesca D.; Kraus Christina N.; Elsensohn Ashley N.; Carley Sama K.; Lehmer Larisa M.; Nguyen Rebecca T.; Linden Kenneth G.; Shiu Jessica

首页> 外文期刊>Journal of the American Academy of Dermatology >Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review

【24h】

Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review

机译：编程的细胞死亡1蛋白和编程死亡 - 配体1抑制剂在治疗非梅兰诺肿瘤皮肤癌症中：系统审查

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Immunotherapy using programmed cell death 1 protein (PD-1) or programmed death-ligand 1 (PD-L1) inhibitors has been increasingly reported in a variety of nonmelanoma skin cancers (NMSCs).

机译：背景技术使用编程的细胞死亡1蛋白（PD-1）或编程死亡 - 配体1（PD-L1）抑制剂的免疫疗法已越来越多地报告在各种非曼洲皮肤癌（NMSC）中。

著录项

来源
《Journal of the American Academy of Dermatology》 |2020年第2期|共20页
作者
Choi Franchesca D.; Kraus Christina N.; Elsensohn Ashley N.; Carley Sama K.; Lehmer Larisa M.; Nguyen Rebecca T.; Linden Kenneth G.; Shiu Jessica;
展开▼
作者单位

Univ Calif Irvine Dept Dermatol 118 Med Surge 1 Irvine CA 92697 USA;

Univ Calif Irvine Dept Dermatol 118 Med Surge 1 Irvine CA 92697 USA;

Univ Calif Irvine Dept Dermatol 118 Med Surge 1 Irvine CA 92697 USA;

Univ Calif Irvine Dept Dermatol 118 Med Surge 1 Irvine CA 92697 USA;

Univ Calif Irvine Dept Dermatol 118 Med Surge 1 Irvine CA 92697 USA;

Univ Michigan Sch Med Ann Arbor MI 48109 USA;

Univ Calif Irvine Dept Dermatol 118 Med Surge 1 Irvine CA 92697 USA;

Univ Calif Irvine Dept Dermatol 118 Med Surge 1 Irvine CA 92697 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词
BCC; cutaneous lymphoma; MCC; NMSCs; nonmelanoma skin cancers; PD-1 inhibitors; PD-L1 inhibitors; sarcomas; SCC; sebaceous carcinoma;

机译：BCC;皮肤淋巴瘤;MCC;NMSCs;非蛋白酶瘤皮肤癌;PD-1抑制剂;PD-L1抑制剂;肉瘤;SCC;SCC;皮脂腺癌;

相似文献

外文文献
中文文献
专利

1. Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review [J] . Choi Franchesca D., Kraus Christina N., Elsensohn Ashley N., Journal of the American Academy of Dermatology . 2020,第2期

机译：编程的细胞死亡1蛋白和编程死亡 - 配体1抑制剂在治疗非梅兰诺肿瘤皮肤癌症中：系统审查
2. Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis [J] . Xiaoying Sun, Raheleh Roudi, Ting Dai, BMC Cancer . 2019,第1期

机译：免疫相关的不良事件与编程的细胞死亡蛋白-1和编程的细胞死亡配体1用于非小细胞肺癌的抑制剂：PRISMA系统审查和META分析
3. Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer [J] . Bari Shahla, Muzaffar Jameel, Chan Austin, Journal of oncology . 2019,第Pta1期

机译：编程的细胞死亡蛋白1（PD-1）的结果和编程的死亡 - 配体1（PD-L1）抑制剂治疗HIV患者的晚期癌症
4. Photoacoustic spectral analysis to sense programmed erythrocyte cell death (eryptosis) for monitoring cancer response to treatment [C] . Muhannad N. Fadhel, Fayruz Kibria, Michael C. Kolios Conference on photons plus ultrasound: imaging and sensing . 2016

机译：光声光谱分析可感知程序性红细胞死亡（加密），以监测癌症对治疗的反应
5. Pattern of programmed cell death-ligand 1 expression and CD8-positive T-cell infiltration before and after chemoradiotherapy in rectal cancer [D] . Ogura Atsushi, 小倉淳司 2019

机译：直肠癌放化疗前后程序性细胞死亡配体1表达和CD8阳性T细胞浸润的模式
6. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis Clinicopathological Factors and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis [O] . Chen Zhang, Qing Yang 2020

机译：编程细胞死亡配体1表达预后临床病理因子和对妇科癌症患者编程细胞死亡-1 /编程细胞死亡 - 配体1抑制剂的预测值表达的预测值以及对妇科癌症患者的抑制剂：荟萃分析
7. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis [O] . Chen Zhang, Qing Yang 2021

机译：编程细胞死亡配体1表达预后，临床病理因子和对妇科癌症患者编程细胞死亡-1 /编程细胞死亡 - 配体1抑制剂的预测值表达的预测值，以及对妇科癌症患者的抑制剂：荟萃分析
8. Bacterial Effector Proteins Which Inhibit Programmed Cell Death. [R] . Martin, G. B., Abramovitch, R. B., Lin, N. C., 2003

机译：抑制程序性细胞死亡的细菌效应蛋白。

Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review

摘要

著录项

相似文献

相关主题

期刊订阅